Skip to main content
Terug
Watch Compare

HARVARD BIOSCIENCE INC

Datakwaliteit: 100%
HBIO
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 4,31
▼ € 1,06 (-19,74%)
Marktkapitalisatie: 24,06 M
Prijs
€ 5,38
Marktkapitalisatie
24,06 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -7,63% annually over 5 years
Debt/Equity of 2,41 — high leverage
Generating 5,47 M in free cash flow
Capital efficient — spends only 1,45% of revenue on capex

Groei

Revenue Growth (5Y)
-7,63%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-8,06%
Earnings (1Y)N/A
FCF Growth (3Y)-33,14%

Kwaliteit

Return on Equity
-380,52%
Onder sectorgemiddelde (-53,53%)
ROIC-158,30%
Net Margin-65,51%
Op. Margin-56,13%

Veiligheid

Debt / Equity
2,41
Boven sectorgemiddelde (0,31)
Current Ratio0,81
Interest Coverage-13,49

Waardering

PE (TTM|2027)
-0,42 | 6,73
Boven sectorgemiddelde (-1,48)
P/B Ratio1,71
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 -1,5
P/B 1,7 1,6
ROE % -380,5 -53,5
Net Margin % -65,5 -41,5
Rev Growth 5Y % -7,6 1,8
D/E 2,4 0,3

Koersdoel Analisten

1 analist
Buy
Huidig
€ 4,31
+39.2%
Koersdoel
€ 6,00
€ 6,00
€ 6,00
€ 6,00
Vooruitzicht
Forward K/W 5,39
Forward WPA € 0,80
WPA Groei (sch.) +300,0%
Omzet Sch. 96,50 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 0,80
€ 0,80 – € 0,80
 96,50 M 1
FY2026 € 0,20
€ 0,20 – € 0,20
 88,90 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 € 0,35 € 0,00 -100,0%
Q32025 € 0,05 € 0,00 -100,0%
Q22025 -€ 0,25 -€ 0,10 +60,0%
Q12025 -€ 0,40 -€ 0,10 +75,0%

ETFs Holding This Stock

GMNAX GMNAX
0,30% weight
GMNCX GMNCX
0,30% weight
GAMNX GAMNX
0,30% weight
GGMMX GGMMX
0,30% weight
BRSIX BRSIX
0,04% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,00% weight
BDSKX BDSKX
0,00% weight
BDSCX BDSCX
0,00% weight
BDSAX BDSAX
0,00% weight
BDSIX BDSIX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8,06% Revenue Growth (3Y) -12,19%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -7,63% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 86,55 M Net Income (TTM) -56,70 M
ROE -380,52% ROA -71,73%
Gross Margin 57,67% Operating Margin -56,13%
Net Margin -65,51% Free Cash Flow (TTM) 5,47 M
ROIC -158,30% FCF Growth (3Y) -33,14%
Safety
Debt / Equity 2,41 Current Ratio 0,81
Interest Coverage -13,49 Asset Turnover 1,10
Working Capital -10,59 M Tangible Book Value -3,84 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,42 Forward P/E N/A
P/B Ratio 1,71 P/S Ratio 0,28
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 22,74%
Market Cap 24,06 M Enterprise Value 51,21 M
Per Share
EPS (Diluted TTM) -1,28 Revenue / Share 19,35
FCF / Share 1,22 OCF / Share 1,50
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,45% FCF Conversion -9,65%
SBC-Adj. FCF 3,02 M Growth Momentum -0,43

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 86,55 M 94,14 M 112,25 M 113,34 M 118,90 M
Net Income -56,70 M -12,41 M -3,42 M -9,52 M -288.000,0
EPS (Diluted) -1,28 -0,28 -0,08 — —
Gross Profit 49,91 M 54,77 M 66,07 M 60,82 M 67,65 M
Operating Income -48,58 M -6,21 M 1,89 M -6,93 M 2,07 M
EBITDA — — — — —
R&D Expenses 8,83 M 10,41 M 11,76 M 12,33 M 10,80 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 3,60 M — — — —
Income Tax -686.000,0 740.000,0 859.000,0 337.000,0 148.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 80,07 M 126,64 M 137,37 M 145,36 M 162,34 M
Total Liabilities 66,34 M 63,30 M 64,29 M 73,14 M 78,94 M
Shareholders' Equity 13,73 M 63,34 M 73,07 M 72,22 M 83,40 M
Total Debt 35,87 M 36,96 M 36,56 M 46,82 M 48,33 M
Cash & Equivalents 8,61 M 4,11 M 4,28 M 4,51 M 7,82 M
Current Assets 48,23 M 45,12 M 49,04 M 51,12 M 61,58 M
Current Liabilities 21,96 M 54,96 M 26,54 M 23,25 M 25,32 M